Boston, May 30, 2024 Canada, March 23, 2020 /PRNewswire/ — Sapphiros, a leading consumer diagnostics company, has launched a new direct-to-consumer wellness brand, NowFuture™. Initial products include a suite of genomic tests that provide personalized insights into nutrition, fitness and sleep, empowering consumers to proactively manage a healthy lifestyle. The future diagnostics portfolio will expand beyond genetics to include at-home blood collection, women’s health, and other infectious disease tests.
Introducing NowFuture
“Navigating your health journey has never been easier. NowFuture™ provides a user-friendly platform that allows individuals to seamlessly access test results and personalized recommendations through a secure portal,” said David Schneider, president and CEO of NowFuture. Ryan SchmidtGeneral Manager of NowFuture™.
Consumers can order directly starting today at NowFuture.com, Amazon.com or through select retail partners to get started making informed lifestyle choices specific to their DNA.
About NowFuture
NowFuture™ is an innovative consumer diagnostics brand with a privacy-first mission to provide individuals with the tools to take control of their personal health and wellness. NowFuture’s genomic nutrition, fitness and sleep tests are the first services that will serve as the foundation for a broader diagnostics portfolio of health and wellness solutions.
About Safiros
Sapphiros, LLC is a privately held consumer diagnostics company backed by KKR and Neoenta. Sapphiros’ portfolio of capabilities and technologies includes novel sample collection, next-generation diagnostics, computational biology and printed electronics, enabling consumers to access critical diagnostic results around the world.
Knowing the Now Moves Us™
Further information: Sapphiros, [email protected]
Website: https://www.nowfuture.com/
Source: Sappiros
